Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Journal of Clinical and Experimental Hematopathology : JCEH|March 18, 2021
Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108ATomohiro Kinoshita, Takashi Watanabe, Kuniaki Itoh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group studyMotoko Yamaguchi, Yok-Lam Kwong, Won Seog Kim, et al.Blood|January 25, 2002
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patientsMotoko Yamaguchi, Masao Seto, Masataka Okamoto, et al.Cancer Science|April 24, 2010
Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patientsKazuyuki Shimada, Takuhei Murase, Kosei Matsue, et al.Cancer Science|September 4, 2014
Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapyMotoko Yamaguchi, Katsuyoshi Takata, Tadashi Yoshino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, et al.Haematologica|June 17, 2008
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patientsMotoko Yamaguchi, Naoya Nakamura, Ritsuro Suzuki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal typeYoshinori Ito, Hiroshi Kimura, Yoshinobu Maeda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi, et al.Cancer Science|May 4, 2021
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphomaYasuhito Terui, Shinya Rai, Koji Izutsu, et al.Pageof 8